{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:21:33Z","timestamp":1793226093787,"version":"4.5.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1097\/iae.0000000000001114","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T23:33:26Z","timestamp":1469662406000},"page":"173-178","source":"Crossref","is-referenced-by-count":18,"title":["TOLERANCE OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN PATIENTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA"],"prefix":"10.1097","volume":"37","author":[{"given":"Anne-Laure","family":"Vi\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Kodjikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Malcl\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Agard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Voirin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussam","family":"El Chehab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh-Minh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Dot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210130","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","article-title":"Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results","volume":"118","author":"Haller","year":"2011","journal-title":"Ophthalmology"},{"key":"R2-21-20210130","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","article-title":"Three-year, randomized, sham-controlled trial of dexamethazone intravitreal implant in patients with diabetic macular edema","volume":"121","author":"Boyer","year":"2014","journal-title":"Ophtalmology"},{"key":"R3-21-20210130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"R4-21-20210130","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/bjophthalmol-2014-306159","article-title":"Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study","volume":"99","author":"Bellocq","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R5-21-20210130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.survophthal.2012.08.003","article-title":"Intraocular pressure monitoring post intravitreal steroids: a systematic review","volume":"58","author":"Kiddee","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"R6-21-20210130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ophtha.2003.03.002","article-title":"Intraocular pressure abnormalities associated with centre and hemicentral retinal vein occlusion","volume":"111","author":"Hayreh","year":"2004","journal-title":"Ophtalmology"},{"key":"R7-21-20210130","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/archopht.1963.00960050502012","article-title":"Corticosteroids and intraocular pressure","volume":"70","author":"Becker","year":"1963","journal-title":"Arch Ophthalmol"},{"key":"R8-21-20210130","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/IAE.0000000000000524","article-title":"Observed complications from dexamethasone intravitreal implant for the treatment of macular edema in retinal vein occlusion over 3 treatment rounds","volume":"35","author":"Reid","year":"2015","journal-title":"Retina"},{"key":"R9-21-20210130","first-page":"805","article-title":"Cortisone et tension oculaire [in French]","volume":"187","author":"Fran\u00e7ois","year":"1954","journal-title":"Ann Ocul (Paris"},{"key":"R10-21-20210130","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archopht.1963.00960050484010","article-title":"Effect of corticosteroids on intraocular pressure and fluid dynamics: I. the effect of dexamethasone in the normal eye","volume":"70","author":"Armaly","year":"1963","journal-title":"Arch Ophthalmol"},{"key":"R11-21-20210130","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/archopht.1963.00960050494011","article-title":"Effect of corticosteroids on intraocular pressure and fluid dynamics. II. The effect of dexamethasone in the glaucomatous eye","volume":"70","author":"Armaly","year":"1963","journal-title":"Arch Ophthalmol"},{"key":"R12-21-20210130","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/IAE.0b013e31816079e8","article-title":"Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors","volume":"28","author":"Vasconcelos-Santos","year":"2008","journal-title":"Retina"},{"key":"R13-21-20210130","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/IAE.0000000000000750","article-title":"Evaluation of multiple dexamethasone intravitreal implant patients with macular edema associated with retinal vein occlusion","volume":"36","author":"Bakri","year":"2016","journal-title":"Retina"},{"key":"R14-21-20210130","doi-asserted-by":"crossref","first-page":"e584","DOI":"10.1111\/aos.12190","article-title":"Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice","volume":"91","author":"Matonti","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"R15-21-20210130","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5301\/ejo.5000585","article-title":"Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion","volume":"25","author":"Caillaux","year":"2015","journal-title":"Eur J Ophthalmol"},{"key":"R16-21-20210130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ophtha.2008.10.002","article-title":"Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection","volume":"116","author":"Roth","year":"2009","journal-title":"Ophthalmology"},{"key":"R17-21-20210130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/IAE.0b013e318297f842","article-title":"Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study)","volume":"34","author":"Capone","year":"2014","journal-title":"Retina"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000001114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:16:07Z","timestamp":1620954967000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201701000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000001114","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}